Symbols

PLSE

Pulse Biosciences·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 1

Stock Price Surged Significantly

Ample Liquidity

Negative Gross Margin

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About PLSE

Pulse Biosciences, Inc.

A novel bioelectric medicine company that develops medical devices based on a nano-pulse electro signaing platform for the treatment of tumors

Industry

Healthcare Equipment and Supplies

Established Date

05/19/2014

Listing Date

05/18/2016

Exchange

NASDAQ Stock Exchange

Full-time Employees

116

Fiscal Year Ends

12-31

Website

www.pulsebiosciences.com

Security Type

Common stock

Office address

601 Brickell Key Drive, Suite 1080, Miami, FL 33131

Business

Introduction

Pulse Biosciences, Inc. was originally incorporated in Nevada on May 19, 2014. Effective June 18, 2018, the Company was re-registered as a Delaware corporation. The Company is a novel ablation company dedicated to healthy innovations using its patented Nano-Pulse Stimulation (" NPS ") technology, a revolutionary energy mode that delivers electrical pulses of nanosecond duration, each of which is less than one millionth of a second in length, to remove or kill target cells in a non-thermal manner. NPS technology, also known as nanosecond pulse field ablation (" nsPFA ") technology, when used to ablate cellular tissue, can be used to treat a variety of diseases for which no optimal solution has been found.

Company Financials

EPS

PLSE has released its 2025 Q4 earnings. EPS was reported at -0.26, versus the expected -0.33, beating expectations. The chart below visualizes how PLSE has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

PLSE has released its 2025 Q4 earnings report, with revenue of 264.00K, reflecting a YoY change of NaN%, and net profit of -17.43M, showing a YoY change of 10.07%. The Sankey diagram below clearly presents PLSE's revenue sources and cost distribution.